- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 2.17M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 3.1M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 7.08M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.78M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.1M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $114.62K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.99M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $10.89M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $40.92M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.08M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.34M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $11.61M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $42.63M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $11.75M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $43.02M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.20 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.20 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.47M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $856.92K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$619.27K |
| Net Income restated | Q1 2026 · Mar 31, 2025 | $26.39K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.29M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$716.14K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $186.02K |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $140.78K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $160.69K |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $171.97K |
| Revenue | Q1 2026 · Mar 31, 2026 | $346.71K |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $312.74K |
| Capex restated | Q1 2026 · Mar 31, 2025 | $1.16K |